Bridging the 'Valley of Death': Comprehensive Solutions for Pain Points in Bio-manufacturing Pilot-Scale Platform Development

Pilot-Scale Platform: A Critical Step in Translating Laboratory Research Findings into Industrial Production in the Field of Biomanufacturing. It Simulates Actual Production Environments to Verify and Optimize the Feasibility of Technologies for Large-Scale Manufacturing.

The successful implementation of pilot-scale trials in biomanufacturing is crucial for accelerating the commercialization of scientific and technological achievements. It not only validates the practicality of the technology but also provides a basis for corporate investment decisions. However, building an efficient pilot-scale platform presents significant challenges, as it requires comprehensive consideration of multiple factors—including technology, equipment, processes, environment, and cost—and demands interdisciplinary knowledge and practical experience.

Some refer to pilot-scale platform validation as the “valley of death” in biomanufacturing; only by crossing this “valley of death” can large-scale commercial production be achieved. Given the myriad complexities involved, what are the core considerations for pilot-scale biomanufacturing? We have attempted to outline them below:

Who can address these pain points and challenges, and what lessons can be drawn from prior experience? The Tianjin Institute of Industrial Biotechnology of the Chinese Academy of Sciences, Bloomage Biotech, Dr. Fang, and VCBeat have jointly launched the training course “Ideas and Solutions for Building Pilot-Scale Platforms in Bio-Manufacturing (2024).” Leveraging the proven expertise of institutions such as the Tianjin Institute of Industrial Biotechnology, CAS, and Bloomage Biotech, the course helps bio-manufacturing enterprises overcome critical pain points and challenges in a single, comprehensive step.

(I) Training Objectives

1. Assist entities preparing to establish or currently constructing pilot-scale platforms for biomanufacturing in clarifying their strategic approach and avoiding common pitfalls

2. Help entities with established pilot-scale platforms improve operational efficiency and precisely connect with partners

3. Guidance on the Construction and Operation of Pilot-Scale Platforms for Different Industries (Pharmaceuticals, Food, Skincare, Bio-based Materials, etc.), along with Case Studies

(II) Target Audience for Training

1. Key personnel from government agencies, pilot-scale testing platforms in industrial parks, or investment promotion and investment platforms

2. Key personnel of pilot-scale platforms at established enterprises in the biomanufacturing sector

3. Core Personnel of the Pilot-Scale Platform at Biotechnology Application Enterprises

4. Key personnel at supply chain enterprises in the field of biomanufacturing

Training Name: Training on Strategies and Plans for the Construction of Pilot-Scale Platforms in Biomanufacturing (2024)

Training Duration: September 23-24, 2024 (tentative)

Training Location: Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences

Training Scale: 60-80 attendees (limited venue capacity; first come, first served)

Organizer：Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences; Professional Committee on Scientific and Technological Development and Consultation, Chinese Society for Microbiology; Bloomage Biotechnology Corporation Limited

Organizer:Dr. Fang, Beijing Danhuang Technology Co., Ltd. (VCBeat)

Total Duration: 2 Days, Including 1.5 Days (10 Hours) of Theoretical Study and 0.5 Days (2 Hours) of Pilot Platform Inspection

Training Topic: Overall Approach to the Construction and Operation of Pilot-Scale Production Platforms

Training Guest:Sun Jibin, Research FellowTianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences

Training Outline:

1. Domestic and International Landscape and Development Trends of the Biomanufacturing Industry

2. The Importance of Pilot-Scale Platforms to National, Local, and Enterprise Development

3. Positioning and Functions of the Biomanufacturing Pilot-Scale Platform: Process Optimization, Scale-up Trials, Process Package Development, Application Development, Technology Transfer and Incubation

4. Construction Content and Overall Framework of the Biomanufacturing Pilot-Scale Platform, Including Pilot Fermentation, Downstream Processing, Industry R&D Laboratories, Analytical Testing Laboratories, and Utilities

5. Construction, Operation Models, and Sustainable Development of Pilot-Scale Platforms for Biomanufacturing, Including Funding, Talent, Projects, Management, Services, and Government-Enterprise Relations

Training Topic: Background, Challenges, and Solutions for the Construction of High-Throughput Fermentation Modules in Pilot-Scale Platforms

Training Speakers:Researcher Xia Jianye, Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences

Training Outline:

Background, Challenges, and Solutions for the Construction of the High-Throughput Fermentation Module in the Pilot-Scale Platform (Part I)

1. Revolutionary Advances Brought by Synthetic Biology Biofoundries and the Bottlenecks in Industrializing Their Outcomes

• The Paradigm Shift in Research Driven by Automated Equipment for High-Throughput Strain Construction

• The Significant Discrepancy Between High-Throughput Strain Screening Standards and Industrial Environments

• Problems and Challenges Arising from Insufficient Fermentation Optimization Throughput

2. High-Throughput Fermentation Optimization: The Key Hardware System for Resolving Bottlenecks

• Research Progress and Development Trends at Home and Abroad

• Application Status of Mature, Commercialized Products

• Development and Existing Deficiencies of Domestic Equipment Technology

3. High-throughput fermentation optimization is the key software technology for addressing bottlenecks

• High-Throughput Experimental Design Methods

• High-Throughput Process Data Analysis Methods

• Applications of Data Science and Artificial Intelligence

Background, Challenges, and Solutions for the Construction of the High-Throughput Fermentation Module of the Pilot-Scale Platform (Part II)

4. Digitalization and Intelligence in the Construction of Pilot-Scale Platforms for Biomanufacturing

• Intelligent Sensing Infrastructure for Biomanufacturing Processes

• Digital Twins and Intelligent Decision-Making in Biomanufacturing Processes

• Possible Pathways to Achieve Intelligent Biomanufacturing Processes

5. Talent Requirements for the Development of Pilot-Scale Biomanufacturing Platforms

• Demand for Multidisciplinary Talent in Biomanufacturing Processes

• Cultivation of Interdisciplinary Talents in Biomanufacturing Processes

• The Critical Role of Technical Managers in Biomanufacturing Processes

6. Reflections on the Operational Mechanism of Pilot-Scale Platforms in Biomanufacturing

• Construction of a Credible Public Technical Service Platform

• Mission and Responsibility of the Public Technical Service Platform

• Potential Operating Mechanisms for the Privatization of Pilot-Scale Platforms

Training Topic: Background, Challenges, and Solutions for the Construction of the Separation Module in the Fermentation Pilot-Scale Platform

Training Guest: Fu Shaoping, Senior Engineer (Professorial Level), Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences

Training Outline:

I. Background for the Construction of the Separation Module of the Fermentation Pilot-Scale Platform

II. Equipment Selection for the Separation Module of the Fermentation Pilot-Scale Platform

2.1 Principles for Centrifuge Equipment Selection

2.2 Principles for Selection of Membrane Separation Equipment

2.3 Principles for Selecting Drying Equipment

III. Services for the Separation Module of the Fermentation Pilot-Scale Platform Project

3.1 Separation Module for Internal Project Services

3.2 External Project Services of the Separation Module

IV. Product Cases of the Separation Module in the Fermentation Pilot-Scale Platform

4.1 Case Studies on the Separation and Purification of Fermented Natural Products

4.2 Case Studies on the Separation and Purification of Fermentation Chemical Products

4.3 Case Study on the Separation and Purification of Fermented Plastic Monomers

4.4 Case Study on the Isolation and Purification of Large Fermented Protein Molecules

V. Technical System of the Separation Module for the Fermentation Pilot-Scale Platform

VI. Next-Generation Digital, Flexible, and Intelligent Platform

Training Topic: Construction, Operation, and Application of Bloomage Biotech's Pilot-Scale Platform

Training Speakers:Wang Enxu, Assistant General Manager of the Pilot Scale Achievement Transformation Center at Bloomage Biotech

Training Outline:

●1. Significance and Positioning of Bloomage Biotech’s Pilot-Scale Platform Construction

1.1 Background & Significance of Pilot-Scale Platform Construction

1.2 Positioning of the Pilot-Scale Platform Development

●2. Characteristics and Capabilities of Bloomage Biotech’s Pilot-Scale Production Platform

2.1 Characteristics of Pilot-Scale Platform Construction

2.2 Hardware Capabilities of the Pilot-Scale Platform

2.3 Software Infrastructure Capabilities of the Pilot-Scale Platform

●3. Service Model and Advantages of Bloomage Biotech’s Pilot-Scale Platform

3.1 Service Model of the Pilot-Scale Platform

3.2 Service Advantages of the Pilot-Scale Platform

3.3 Service Cases of the Pilot-Scale Platform

●4. Future Outlook

Training Topic: Development Concepts and Solutions for a Biomanufacturing Application Platform Targeting the Food Sector

Training Speakers:Professor Xia Xiaole, Academic Dean of the College of Food Science and Engineering at Tianjin University of Science and Technology, and Professor at the School of Biotechnology, Jiangnan University

Training Outline:

●1. Background and Challenges in Building a Development Platform for Biomanufacturing Applications in the Food Sector

1.1 Background of Biomanufacturing in the Food Sector

1.2 Significance of Platform Development: Promoting the Transformation and Upgrading of the Food Industry

1.3 Challenges in Building Food Biomanufacturing Platforms

●2. Research and Innovation in Platform Technologies for the Development of Biomanufacturing Applications in the Food Sector

2.1 Process Innovation in Food Biomanufacturing Platforms

2.2 Nutritional Evaluation of Food Bio-Manufacturing Platforms

2.3 Toxicological Studies on Food Bio-manufacturing Platforms

2.4 Applications of Food Bio-Manufacturing Platforms

●3. Intelligent Construction of Biomanufacturing Platforms in the Food Sector

3.1 Hardware Specifications and Configuration for Food Biomanufacturing

3.2 Talent Requirements for the Food Biomanufacturing Platform

3.3 Management and Strategic Planning of the Food Bio-Manufacturing Platform

●4. Summary and Outlook

4.1 The Role of Platforms in Driving Technological Innovation in the Food Industry

4.2 Prospects for the Long-Term Impact of Platforms on Sustainable Development in the Food Industry

Training Topic: Development Concepts and Solutions for Building a Biomanufacturing Application Platform Targeting Cosmetic-Grade and Pharmaceutical-Grade Products

Training Speakers:Xue Guoxi, Process Director, Pilot Scale-up and Technology Transfer Center, Bloomage Biotech

Training Outline:

●1. Background and Challenges in Building a Biomanufacturing Application Development Platform for the Cosmetics and Pharmaceutical Sectors

1.1 Background of Biomanufacturing in the Cosmetics and Pharmaceutical Fields

1.2 Significance of Platform Development: Driving the Transformation and Upgrading of the Pharmaceutical Industry

1.3 Challenges Facing the Construction of Cosmetics and Biopharmaceutical Manufacturing Platforms

●2. Intelligent Construction Strategies for Biomanufacturing Platforms in the Cosmetics and Pharmaceutical Fields

2.1 Hardware Specifications and Configuration of the Pilot-Scale Platform

2.2 Architectural Setup and Talent Requirements for the Pilot-Scale Platform

2.3 Matching of Supporting Facilities

●3. Key Points in the Operation of Biomanufacturing Platforms in the Cosmetics and Pharmaceutical Fields

3.1 Quality System Level

3.2 Registration Level

3.3 Confidentiality Aspects

●4. Summary and Outlook

Training Topic: Case Studies on Application Development of Bio-manufacturing Products

Training Guest: Rong Jinlei, Process Director of the Pilot Scale-up Achievement Transformation Center at Bloomage Biotech

Training Outline:

●1. Conditions Required for Pilot-Scale Amplification

1.1 Process Stability and Product Stability

1.2 Operating Conditions, Raw and Auxiliary Materials, and Three Wastes Issues

1.3 Process Safety

●2. Common Issues in Pilot-Scale Scale-Up

2.1 Device Compatibility and Tolerance

2.2 Performance Variations of the Device

2.3 Differences in Raw and Auxiliary Materials During Scale-Up

●3. Bloomage Pilot-Scale Case Study

3.1 Risks in the Pilot-Scale Amplification Process of BL-21 Series Strains

3.2 Process Control During E. coli Scale-Up

3.3 Process Optimization During Pilot-Scale Up

*More training outlines are continuously being updated

● Researcher Xia Jianye, Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences

Xia Jianye, Researcher and Doctoral Supervisor, is a recipient of the Chinese Academy of Sciences’ “Hundred Talents Program” and a Leading Talent in Tianjin. He serves as Vice Chairman of the Special Committee on Biochemical Process Modeling and Control under the Chinese Society for Microbiology, and currently holds the position of Director of the Pilot Scale Platform for Intelligent Biomanufacturing at the Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences (CAS).Dr. Xia received his Ph.D. from East China University of Science and Technology in 2008, studying under Professor Zhang Siliang. He proposed a fermentation process optimization and scale-up method based on the integration of reactor flow fields and cellular physiology, which has been successfully applied in numerous biomanufacturing enterprises across China. His accolades include one Second Prize of the National Science and Technology Progress Award, one First Prize of the Shanghai Science and Technology Progress Award, and one Second Prize of the Science and Technology Progress Award from the China National Light Industry Council. He has published more than 30 research papers in prestigious journals such as *Cell*, *Nature Communications*, *Biotechnology and Bioengineering*, and *Trends in Biotechnology*, and holds five authorized patents.In July 2021, Dr. Xia joined the Tianjin Institute of Industrial Biotechnology, CAS, as a full-time researcher. He was responsible for establishing the laboratory platform of the Center for Intelligent Biomanufacturing and built a 6,000-square-meter digitalized and intelligent biomanufacturing pilot scale platform. By innovating the technical service mechanisms of the pilot platform, he facilitated the industrial translation of three synthetic biology products from the laboratory to commercial production.

● Researcher Sun Jibin, Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences

August 2020–Present, Director of the Center for Systems Biology, Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences

Research Fields: Systems biology of industrial microorganisms; multi-omics technologies; synthetic biology technologies; design and development of industrial microbial strains

● Fu Shaoping, Senior Engineer (Professor-level), Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences

Fu Shaoping, male, born in 1978, holds a Ph.D., is a Senior Member of the Chinese Chemical Society, and serves as a Professor-level Senior Engineer at the Center for Intelligent Biomanufacturing, Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences. He obtained his Ph.D. in Analytical Chemistry from the Dalian Institute of Chemical Physics, Chinese Academy of Sciences, in March 2006. In the same year, he joined the School of Biological and Food Engineering at Dalian Polytechnic University. From 2008 to 2009, he conducted research on the separation and structural identification of complex components of plant natural products at the Universidad de Granada in Spain. In October 2012, he joined the Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, where his main research focus has been on the separation and purification processes of bio-fermentation products. He has presided over key projects under the Tianjin Municipal Science and Technology Support Program and the National Key R&D Program of China. He was responsible for completing the development of separation and purification processes for more than thirty industrialization projects involving products such as lycopene, inositol, and protocatechuic acid, generating significant economic value. His honors include the Second Prize of the Dalian Municipal Science and Technology Progress Award (2010), the Second Prize of the Liaoning Provincial Science and Technology Progress Award (2011), selection as a candidate for Tianjin’s “Program to Introduce More Than 1,000 High-Level Talents Within Three Years” (2012), selection as a Tier II candidate for the Tianjin Binhai New Area “131” Talent Training Project (2013), recognition as a “Key Technical Talent of the Chinese Academy of Sciences” (2019), and appointment to the “Distinguished Research Backbone Position” of the Chinese Academy of Sciences (2022).

● Professor Xia Xiaole, Academic Dean of the College of Food Science and Engineering at Tianjin University of Science and Technology, and Professor at the School of Biotechnology, Jiangnan University

Primary Research Areas:

1. Future Fermented Foods

Based on evolutionary analysis, synthetic biology and computational biology approaches are employed to identify, analyze interactions, and reconstruct the core microbiota of traditional fermented foods, with the aim of addressing issues such as food safety and flavor enhancement in industrial practice.

2. Synthetic Bio-manufacturing of Active Macromolecules

Health-RelatedActivityMacromolecules, such as lipopeptides, hydrolases, and Monacolin K, leverage computational biology and synthetic biology to address challenges in their synthesis, expression, and engineering, with applications in the life and health sectors.

● Rong Jinlei, Process Director of the Pilot Scale-up and Technology Transfer Center at Bloomage Biotech

Rong Jinlei, holding a master’s degree, currently serves as the Process Director at the Pilot Scale Achievement Transformation Center of Bloomage Biotech (Tianjin) Co., Ltd. With nearly two decades of specialized experience in the development and optimization of microbial fermentation, extraction, and purification processes, he has accumulated extensive expertise in project development and scale-up for active pharmaceutical ingredients (APIs) of small-molecule bioactives, antibiotics, peptides, proteins, and macromolecular polysaccharides. He has achieved outstanding results in optimizing industrial fermentation media, improving fermentation processes, and enhancing separation and purification techniques. The multiple products he has led in development are industry leaders in both cost efficiency and quality. As a key member, he participated in the “Key Technologies and Industrialization Project for Glutathione API and Preparations,” which was awarded the First Prize for Provincial Scientific and Technological Progress.

● Wang Enxu, Assistant General Manager of the Pilot Scale Achievement Transformation Center at Bloomage Biotech

Wang Enxu, Ph.D. candidate, Senior Engineer (Associate Professor level), Adjunct Master’s Supervisor at Tianjin University of Science and Technology, currently serves as Assistant General Manager of the Pilot Scale-up and Technology Transfer Center at Bloomage Biotech (Tianjin) Co., Ltd. He possesses comprehensive expertise in end-to-end technologies within synthetic biology, from upstream to downstream processes. With a holistic understanding of process development, scale-up, optimization, and commercial manufacturing of microbial fermentation products, he brings extensive experience in process development and industrial translation, dedicated to tailoring bioprocessing solutions for clients. To date, he has built an elite team of 150 professionals and established in-depth collaborations with numerous prestigious universities and research institutions, successfully completing pilot scale-up and industrial translation for more than 20 bioactive substances. Furthermore, he has participated in or led multiple large-scale projects, including the construction of the Pilot Scale-up and Technology Transfer Center, which involves a total investment exceeding RMB 1 billion and covers an area of 30,000 square meters. This project integrates advanced flexible production line designs, capable of simultaneously supporting pilot experiments and small-scale commercial production for six major categories of substances: functional sugars, proteins, peptides, amino acids, nucleotides, and natural active compounds, thereby laying a solid foundation for the company’s future industrialization strategy.

● Xue Guoxi, Process Director, Pilot Scale-up and Technology Transfer Center, Bloomage Biotech

Xue Guoxi, Master’s Degree HolderWith 16 years of experience in drug research and development at large pharmaceutical companies, Mr. Xue currently serves as the Process Director at the Pilot Scale Achievement Transformation Center of Bloomage Biotech (Tianjin) Co., Ltd. He has led and completed one National Science and Technology Support Program project (valued at RMB 100 million), one major science and technology special project of Shandong Province (valued at RMB 15 million), and one fiscal science and technology plan project of Huayanghe City (valued at RMB 1.5 million). He holds four authorized patents. Mr. Xue has spearheaded the R&D and scale-up of 16 pharmaceutical-, food-, and cosmetic-grade raw materials, three of which generate approximately RMB 500 million in annual profit for the company. He has completed regulatory filing for six microbial fermentation-based drug products, undergoing two FDA inspections and six GMP compliance inspections. Additionally, he was responsible for the design and construction of fermentation and purification workshops with a 500-ton fermentation capacity, and has successively established and operated six R&D and pilot-scale platforms.

*More instructor profiles are being continuously updated.

Intelligent Bio-Manufacturing CenterThe Intelligent Bio-Manufacturing Center is one of the six platform laboratories established under the National Center for Technological Innovation in Synthetic Biology. It serves as a pilot-scale bio-manufacturing platform that provides technical services and conducts key technology R&D, including strain performance validation, pilot process development and verification, trial production of samples ranging from kilograms to hundreds of kilograms, and scale-up of bio-manufacturing processes, thereby facilitating the industrialization of innovative achievements in synthetic biology.Officially approved and established in September 2021, the Center has invested RMB 130 million in equipment construction and built 6,000 square meters of new laboratory space. Its equipment covers the entire chain of bioprocess development, optimization, and scale-up, including high-throughput strain performance validation, high-throughput media optimization, high-throughput fermentation process optimization, and digitalized, intelligent pilot production lines.Focusing on intelligent manufacturing technologies for industrial biological processes, the Center develops key technologies such as strain validation, media optimization, process scale-up, and intelligent bio-manufacturing process packages. It promotes the technological upgrade of traditional fermentation industries toward automation and intelligence, fully supporting the efficient industrial translation of synthetic biology achievements. By significantly reducing the development time and costs associated with transferring high-performance strains from the laboratory to industrial production, the Center provides intelligent manufacturing process packages ready for industrial-scale production.Since its establishment, the Center has actively explored new technical service models. It has introduced a novel pilot-scale service mechanism focused on ensuring core strain safety and innovatively proposed three customized and personalized service models: “Shared Kitchen,” “Shared Chef,” and “Contracted Development.” To date, it has served more than 20 domestic bio-manufacturing enterprises, successfully facilitating the transition of three bio-manufacturing products from laboratory research to industrial production, achieving remarkable results.

Bloomage Biotechnology (688363.SH), established in 2000, is a globally renowned biotechnology and biomaterials company. Driven by synthetic biology, the company is committed to continuously improving quality of life and extending lifespan, delivering healthy, beautiful, and joyful life experiences to humanity. Upholding its corporate mission of “Keeping Every Life Vibrant,” the company primarily focuses on the development and industrial application of bioactive substances beneficial to human health, including functional sugars, proteins, peptides, amino acids, nucleotides, and natural active compounds. As the world’s largest enterprise engaged in the research and development, production, and sales of hyaluronic acid, Bloomage Biotechnology ranks first globally in the industrialization of hyaluronic acid.

Ph.D. in Economics from Zhejiang University; Original Author of the WeChat Official Account “Dr. Fang”

Managing Director at Titanium Capital, overseeing government and corporate ecosystem partnership initiatives, with a focus on synthetic biology, healthcare, and industrial internet sectors.

During my tenure at the High-Tech Division of the Xiamen Municipal Development and Reform Commission, I was responsible for “mass entrepreneurship and innovation” initiatives, including planning for startup parks, drafting and promoting entrepreneurial policies, and implementing policies for high-level talent. Previously, I served in the Strategy Office of the Xiamen Development Research Center, where I led research projects on the Belt and Road Initiative and regional economic trends. I also contributed to the editing of internal reference reports at the Zhejiang Provincial Policy Research Institute, with more than ten reports receiving comments and instructions from senior leaders, including the then Secretary of the Zhejiang Provincial Committee of the Communist Party of China.

He also serves as a Distinguished Research Fellow at the Industrial Research Center of Fudan University’s Zhangjiang Institute, a member of the Expert Advisory Committee at the Xiamen Guoxin Credit Big Data Innovation Research Institute, and an advisor to multiple startup enterprises.

Tech projects involved in investment and financing or provided with consulting services have secured over RMB 10 billion in funding, including AnChang Network, HEC Pharm, Crown Bioscience, Lifechem Pharmaceuticals, Yunyin Technology, and U-Love-Sai.

Expertise: Regional development planning, policy consulting and project applications, business plan writing, pitch coaching for startup projects, corporate business and financial restructuring, and investment and financing matchmaking.

VCBeatFounded in 2014, it is a company that leverages data as its foundation, research as its core, and brand media as its connector to facilitate the precise aggregation of industrial resources and help industry changemakers achieve rapid growth.Innovative Industrial Service Agency. Egg Yolk Technology focuses on the life and health sector, providing services such as brand communication, research consulting, data monitoring, and resource/project matchmaking to enterprises, scientists, government industrial parks, investment institutions, and other entities within the industry chain. Since its establishment, Egg Yolk Technology has secured investments from multiple renowned firms, including Legend Capital, Baidu Ventures (BV), Honghui Capital, Changling Capital, Yifang Group, and Weilai Capital, achieving a valuation of several hundred million RMB. Under the Egg Yolk Technology umbrellaVCBeat, innovation and investment in China's pharmaceutical, medical, and broader healthcare sectorOne of the Well-Known Media Outlets。